公司动态
公司动态
山东诚汇双达药业有限公司诚挚邀请您莅临?2025日本东京制药原料展览会(CPHI Japan)?，
与我们在?6A-07展位?共话合作机遇，探讨行业前沿趋势!
展会速览
?
时间?：2025年4月9日-11日?
地点?：日本东京有明国际会展中心?
规模?：全球50余国逾800家展商参展，预计吸引超3万名专业观众?
聚焦领域?：原料药、生物试剂、天然提取物、制药技术及法规动态?
作为亚洲制药行业标杆展会，CPHI Japan汇聚全球顶尖企业，是链接技术革新、市场洞察与供应链合作的核心平台?。
日本凭借领先的研发实力与严苛质量标准，持续引领制药行业创新方向?。
我们将携?局麻类、抗病毒类、心脑血管类、抗肿瘤类、兽药原料?等核心产品亮相，展现高纯度原料药与中间体的研发实力?。（部分产品展示如下，如需了解更多产品请联系我们）
| 产品名称 | CAS |
| *Vonoprazan Fumarate | 1260141-27-2 |
| 881681-01-2 | |
| *Letermovir | 917389-32-3 |
| *Dapagliflozin propanediol monohydrate | 960404-48-2 |
| *Crisaborole | 906673-24-3 |
| Sugammadex sodium | 343306-79-6 |
| *Apalutamide | 956104-40-8 |
| *Baloxavir Marboxil | 1985606-14-1 |
| *Lotilaner | 1369852-71-0 |
| *Ruxolitinib Phosphate | 941678-49-5 |
| *Finerenone | 1050477-31-0 |
| *Upadacitinib | 1310726-60-3 |
| *Ozenoxacin | 245765-41-7 |
| *Resmetirom | 920509-32-6 |
| *Fexuprazan HCI | 1902954-87-3 |
| Prilocaine | 721-50-6 |
| Lidocaine HCI | 6108-05-0 |
| Lidocaine | 137-58-6 |
| Ozagrel sodium | 189224-26-8 |
| Celecoxib | 169590-42-5 |
| Ropivacaine HCI | 132112-35-7 |
| Tetracaine HCI | 136-47-0 |
| Tetracaine | 94-24-6 |
| Prilocaine HCI | 1786-81-8 |
| Pramoxine HCI | 637-58-1 |
| Bupivacaine HCI | 73360-54-0 |
| Bupivacaine | 2180-92-9 |
| Articaine HCI | 23964-57-0 |
| Tadalafil | 171596-29-5 |
| Lacidipine | 103890-78-4 |
| Urapidil HCI | 64887-14-5 |
| *Bilastin | 202189-78-4 |
| *Fluralaner | 864731-61-3 |
| *Afoxolaner | 1093861-60-9 |
| *Sarolaner | 1398609-39-6 |
| *Oclacitinib maleate | 1208319-27-0 |
|
兽药中间体 Veterinary intermediates |
|
| 4-acetyl-2-methylbenzoic acid | 55860-35-0 |
| 2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride | 1171331-39-7 |
| 3',5'-dichloro-2,2,2-trifluoroacetophenone | 130336-16-2 |
| 4-acetyl-1-naphthoic acid | 131986-05-5 |
| 1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone | 1125812-58-9 |
| 4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-1-naphthoic acid | 1308362-48-2 |
| Trans-4-aminocyclohexanecarboxylic acid hydrochloride | 27960-59-4 |
| N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate | 1640292-55-2 |
|
玛巴洛沙韦中间体 Baloxavir Marboxil Intermediates |
|
| (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione | 1985607-70-2 |
| 3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid | 119736-16-2 |
| 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | 1985607-83-7 |
|
富马酸伏诺拉生中间体 Vonoprazan Fumarate Intermediates |
|
| 5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde | 881674-56-2 |
| Pyridine-3-sulfonyl chloride | 16133-25-8 |
|
依度沙班中间体 Edoxaban Intermediates |
|
| (1S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1]octan-7-one | 139893-81-5 |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | 1210348-34-7 |
| tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate | 365998-36-3 |
| 2-bromo-5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine;4-methylbenzenesulfonic acid | 852291-42-0 |
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
*The advanced intermediates of all above APIs are available
期待与您同行?
此次参展，我们期待与全球伙伴深化合作，共同应对行业挑战，探索新兴市场机遇。欢迎您莅临?6A-07展位?，通过CPHI Japan这一全球舞台，诚汇双达愿与您携手，共筑制药原料行业新未来!?
联系我们
电话?：+86-531-58897029/7070
邮箱：market@chsdpharma.com
网站：www.chsdpharma.com
2025年4月，东京有明，不见不散!?